ADC Therapeutics SA 10-Q filing
Filed 2026-05-04 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001628280-26-029819
- Form type
- 10-Q
- CIK
- 0001771910
- Primary document
- https://www.sec.gov/Archives/edgar/data/1771910/000162828026029819/adc-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ADC Therapeutics SA.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $20.0M | - | - |
| Operating Income | $-25.2M | - | - |
| Net Income | $-33.0M | - | - |
| Eps Basic | -0.21 | - | - |
| Eps Diluted | -0.21 | - | - |
| Cash And Equivalents | $231.0M | - | - |
| Total Assets | $291.5M | - | - |
| Total Liabilities | $507.9M | - | - |
| Shareholders Equity | $-216.4M | - | - |
| Operating Cash Flow | $-29.7M | - | - |
| Capital Expenditures | $32,000 | - | - |